BioSpace News Archive

Shanghai Junshi Biosciences Co., Ltd, a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announces a new exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, for toripalimab in the Middle East and North Africa.

Harm Reduction Therapeutics, Inc., a 501 nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter naloxone nasal spray available to the public, announced that the FDA has accepted its New Drug Application for OTC RiVive for the emergency treatment of opioid overdose.

Ablaze Pharmaceuticals announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. to develop series of targeted radiopharmaceutical therapy products.